Pharmaceutical company Unichem Laboratories has acquired a 19.99 per cent stake each in Optimus Drugs Pvt Ltd and Optrix Laboratories Pvt Ltd for a total consideration of about $16.5 million (Rs.120 crore). Hyderabad-based Optimus and Optrix, owned and controlled by the same management, are engaged in the business of researching, developing, manufacturing, marketing and distribution of active pharmaceutical ingredients (API) and intermediates. The key objective of the investment is to gain access to the manufacturing facilities of Optimus and Optrix.
Unichem Labs picks 19.99% each in two Optimus Group firms for $16.5m
Date posted: Monday 12 November 2018